614
Participants
Start Date
December 31, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
GW642444M
GW642444M
Placebo
Placebo mulit-dose dry powder inhaler
GSK Investigational Site, Manila
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Edegem
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Liège
GSK Investigational Site, Cavite
GSK Investigational Site, eManzimtoti
GSK Investigational Site, Cape Town
GSK Investigational Site, Cape Town
GSK Investigational Site, Mowbray
GSK Investigational Site, Claremont
GSK Investigational Site, The Bronx
GSK Investigational Site, Berlin
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Bethesda
GSK Investigational Site, Geesthacht
GSK Investigational Site, Raleigh
GSK Investigational Site, Orangeburg
GSK Investigational Site, Hanover
GSK Investigational Site, Toulouse
GSK Investigational Site, Tallahassee
GSK Investigational Site, Valrico
GSK Investigational Site, Montpellier
GSK Investigational Site, Knoxville
GSK Investigational Site, Magdeburg
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Canton
GSK Investigational Site, Cincinnati
GSK Investigational Site, Chiang Mai
GSK Investigational Site, River Forest
GSK Investigational Site, St Louis
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Columbia
GSK Investigational Site, Rolla
GSK Investigational Site, Mannheim
GSK Investigational Site, Wiesloch
GSK Investigational Site, Metairie
GSK Investigational Site, Sunset
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Paris
GSK Investigational Site, Denver
GSK Investigational Site, Coeur d'Alene
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Rolling Hills Estates
GSK Investigational Site, Long Beach
GSK Investigational Site, Long Beach
GSK Investigational Site, San Diego
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Fresno
GSK Investigational Site, Medford
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Ryazan
GSK Investigational Site, Saratov
GSK Investigational Site, Kazan'
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, North Dartmouth
GSK Investigational Site, Skillman
GSK Investigational Site, Providence
GSK Investigational Site, La Plata
GSK Investigational Site, Mendoza
GSK Investigational Site, Brampton
GSK Investigational Site, Mississauga
GSK Investigational Site, Mississauga
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Sainte-Foy
GSK Investigational Site, Trois-Rivières
GSK Investigational Site, Harderwijk
GSK Investigational Site, Heerlen
GSK Investigational Site, Utrecht
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Bialystok
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Krakow
GSK Investigational Site, Lodz
GSK Investigational Site, Lodz
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Cheongju, Chungcheongbuk-do
GSK Investigational Site, Suwon
GSK Investigational Site, Gothenburg
GSK Investigational Site, Lund
Lead Sponsor
GlaxoSmithKline
INDUSTRY